Literature DB >> 26639978

Interactions of visual hallucinations, rapid eye movement sleep behavior disorder and cognitive impairment in Parkinson's disease: A review.

Abhishek Lenka1, Shantala Hegde2, Ketan Ramakant Jhunjhunwala1, Pramod Kumar Pal3.   

Abstract

Patients with Parkinson's disease may develop various non-motor symptoms during the course of the illness. Visual hallucinations (VH) and cognitive impairment (CI) are two common non-motor symptoms of Parkinson's disease. Studies have reported association of both VH and CI with presence of rapid eye movement sleep behavior disorder (RBD). Presence of visual hallucinations and cognitive impairment has been described as risk factors for emergence of each other. There is marked overlap in the risk factors for development of RBD, VH and CI in patients with PD. Results of clinical and epidemiological studies as well as studies based on neuroimaging, electrophysiology especially transcranial magnetic stimulation and neuropsycholgical evaluations in PD patients have suggested presence of certain common neurobiological process leading to emergence of RBD, VH and CI. Structural neuroimaging studies using voxel-based morphometry have often reported grey matter atrophy of hippocampus and parahippocampal cortices in PD patients with RBD, VH and CI. Cholinergic dysfunction is common in PD patients with RBD, VH and CI. This review explores the complex interactions of RBD, VH and CI in patients with PD and their potential implications.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cognitive impairment; Parkinson's disease; Psychosis; RBD; Visual hallucinations

Mesh:

Year:  2015        PMID: 26639978     DOI: 10.1016/j.parkreldis.2015.11.018

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  18 in total

Review 1.  Cortical afferent inhibition abnormalities reveal cholinergic dysfunction in Parkinson's disease: a reappraisal.

Authors:  Raffaele Nardone; Francesco Brigo; Viviana Versace; Yvonne Höller; Frediano Tezzon; Leopold Saltuari; Eugen Trinka; Luca Sebastianelli
Journal:  J Neural Transm (Vienna)       Date:  2017-08-12       Impact factor: 3.575

Review 2.  Parkinson's disease psychosis: therapy tips and the importance of communication between neurologists and psychiatrists.

Authors:  Daniel Martinez-Ramirez; Michael S Okun; Michael S Jaffee
Journal:  Neurodegener Dis Manag       Date:  2016-07-13

Review 3.  Minor hallucinations in Parkinson disease: A subtle symptom with major clinical implications.

Authors:  Abhishek Lenka; Javier Pagonabarraga; Pramod Kumar Pal; Helena Bejr-Kasem; Jaime Kulisvesky
Journal:  Neurology       Date:  2019-07-09       Impact factor: 9.910

Review 4.  The use of nonhuman primate models to understand processes in Parkinson's disease.

Authors:  Javier Blesa; Inés Trigo-Damas; Natalia López-González Del Rey; José A Obeso
Journal:  J Neural Transm (Vienna)       Date:  2017-03-29       Impact factor: 3.575

5.  Preoperative REM Sleep Behavior Disorder and Subthalamic Nucleus Deep Brain Stimulation Outcome in Parkinson Disease 1 Year After Surgery.

Authors:  Elsa Besse-Pinot; Bruno Pereira; Franck Durif; Maria Livia Fantini; Elodie Durand; Bérengère Debilly; Philippe Derost; Caroline Moreau; Elodie Hainque; Tiphaine Rouaud; Alexandre Eusebio; Isabelle Benatru; Sophie Drapier; Dominique Guehl; Olivier Rascol; David Maltête; Ouhaïd Lagha-Boukbiza; Caroline Giordana; Melissa Tir; Stéphane Thobois; Lucie Hopes; Cécile Hubsch; Béchir Jarraya; Anne-Sophie Rolland; Jean-Christophe Corvol; David Devos; Ana Marques
Journal:  Neurology       Date:  2021-10-19       Impact factor: 9.910

Review 6.  Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease.

Authors:  Gunasingh J Masilamoni; Yoland Smith
Journal:  J Neural Transm (Vienna)       Date:  2017-08-31       Impact factor: 3.575

Review 7.  REM sleep behaviour disorder in Parkinson's disease (Review).

Authors:  Ștefania Diaconu; Oana Falup-Pecurariu; Diana Țînț; Cristian Falup-Pecurariu
Journal:  Exp Ther Med       Date:  2021-05-28       Impact factor: 2.447

Review 8.  Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.

Authors:  Anna Chang; Susan H Fox
Journal:  Drugs       Date:  2016-07       Impact factor: 9.546

9.  Risk factors for early psychosis in PD: insights from the Parkinson's Progression Markers Initiative.

Authors:  Dominic H Ffytche; Joana B Pereira; Clive Ballard; K Ray Chaudhuri; Daniel Weintraub; Dag Aarsland
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-04       Impact factor: 10.154

Review 10.  The psychosis spectrum in Parkinson disease.

Authors:  Dominic H Ffytche; Byron Creese; Marios Politis; K Ray Chaudhuri; Daniel Weintraub; Clive Ballard; Dag Aarsland
Journal:  Nat Rev Neurol       Date:  2017-01-20       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.